arrow
H

Herbert H. Loong

prince of wales hospital hong kong
H指数:41
被引数:8,520

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Consensus recommendations for the management of Dato-DXd-associated adverse events in patients with advanced/metastatic NSCLC: insights from a multiregional steering committee

关于Dato-DXd相关不良事件管理的共识建议:多区域指导委员会的见解

2026-08-030
PRE
Asia-Pacific analysis of ESMO study on availability, out-of-pocket costs (OPC) and accessibility of antineoplastic medicines

亚太地区对ESMO研究(关于抗肿瘤药物的可及性、自付费用(OPC)和可及性)的分析

2026-08-010
OAAI
A Propensity-Score Matched Prospective Study on the Impact of TTFields on Overall Survival and Quality of Life in Newly Diagnosed WHO Grade 4 Astrocytoma Patients

一项基于倾向性评分匹配的前瞻性研究,探讨TTFields对新诊断的WHO 4级星形细胞瘤患者总生存期和生活质量的影响

2025-11-010
OAAI
Pattern of failure, impact of local therapy, and characteristics of long-term responders with advanced EGFR mutation positive non-small cell lung cancer treated with first-line osimertinib

失败模式、局部治疗的影响以及接受一线奥希替尼治疗的晚期EGFR突变阳性非小细胞肺癌患者中长期应答者的特征

2025-11-010
PRE
Sevabertinib in Advanced HER2-Mutant Non-Small-Cell Lung Cancer

Sevabertinib治疗晚期HER2-Mutant非小细胞肺癌

2025-10-014
PRE
BOS172738, a selective RET inhibitor, for the treatment of patients with RET-altered tumors including RET-fusion-positive non-small-cell lung cancer and RET-mutant medullary thyroid cancer: a phase I dose-escalation/expansion multicenter study

BOS172738,一种选择性RET抑制剂,用于治疗RET基因变异的肿瘤患者,包括RET融合阳性的非小细胞肺癌和RET突变型甲状腺髓样癌:一项多中心I期剂量递增/扩展研究

2025-09-240
PREAI
Spinal Metastasis from Supratentorial Glioblastoma: A Registry-Based Case Series and a Review of the Literature

松果体胶质母细胞瘤的脊柱转移:一项基于注册的病例系列研究及文献综述

2025-09-230
OAAI
Impact of alternating electric fields therapy for newly diagnosed WHO grade 4 astrocytoma on patient survival: a real-world propensity-score adjusted prospective multicenter study

新诊断的WHO 4级星形细胞瘤的交流电场治疗对患者生存的影响: 一项真实世界倾向评分调整的前瞻性多中心研究

2025-03-010
OAAI
The impact of timing of temozolomide chemoradiotherapy for newly diagnosed glioblastoma on patient overall survival: A multicenter retrospective study

替莫唑胺放化疗对新诊断胶质母细胞瘤患者总生存期影响的多中心回顾性研究

2024-11-120
OAAI
Low-grade fi bromyxoid sarcoma and sclerosing epithelioid fi brosarcoma, outcome of advanced disease: retrospective study from the Ultra-Rare Sarcoma Working Group
2024-09-010
OAAI